Egalet Corp (NASDAQ:EGLT) shares are rising 21% after the specialty pharma company gained a tentative nod from the FDA for an expanded label …
Investors love biotech stocks for the lottery ticket-like returns they can offer if a company strikes medical gold or wins the regulator’s bless. …
Egalet Corp (NASDAQ:EGLT) shares are under pressure following the news that the maker received a complete response letter (CRL) from the FDA regarding the prior approval …
Egalet Corp (NASDAQ:EGLT) shares were sent on a close to 13% rise today after the firm announced this morning that its pipeline drug Egalet-002, …
Egalet Corp (NASDAQ:EGLT) announced yesterday that the FDA had given them notice that they would not be meeting their PDUFA data of Oct …
Biotechnology companies are kicking of pipeline trials for 2016. Analysts weigh in on Merrimack Pharmaceuticals Inc (NASDAQ:MACK) and Egalet Corp (NASDAQ:EGLT) in light …
The first quarter of 2015 has come to a close and companies are still releasing earnings reports. Let’s look back and see which …
